COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis

Banerjee, Jineta; Friedman, Jan M.; Klesse, Laura J.; Yohay, Kaleb; Jordan, Justin; Plotkin, Scott R.; Allaway, Robert J.; Blakeley, Jaishri O.

doi:10.1016/j.gim.2022.10.007

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A recently published paper based on the National COVID Cohort Collaborative electronic health record data showed that severe outcomes of Covid-19 infection were not greater in the NF1 cohort than in other disease cohorts. 12 However, there is still a lack of validated research data to support the vaccination of NF1 patients, which leaves patients’ concerns unaddressed. Based on our analysis of the common symptoms and changes in the condition of NF1 patients after Covid-19 infection and vaccination, we found that the most common symptoms of NF1 patients after infection were fever and cough, which were consistent with the general population and did not differ significantly in incidence.…”

Section: Discussionmentioning

confidence: 99%